Hello #AACR26! From 2-5pm today, check out Session PO.CL07.03 - Targeting DNA Repair, Cell Cycle, and Tumor Metabolism (Section 49), where Tomoo Iwakuma, MD, PhD, contributed to “Depletion of dominant-negative mutant p53 improves the efficacy of mutant p53 reactivators.”